The authors hypothesized that SIRT1 inhibition in other cells within the cancer microenvironment (i.e., fibroblasts, endothelial, and immune cells) may have been involved in the tumor‐promoting activity of 9a. The gene discussed is SIRT1; the disease is neoplasm.